Cancel
Doug Sheehy
Chief Legal Officer and Secretary
@
Sonoma BioTherapeutics
3lfk11z@z2z8tvx2x.8r1
Sign up to see email
Known information
- Received an A.B. in History from Dartmouth College
- Earned a J.D. from American University's Washington College of Law, where he was Editor-in-Chief of the American University Law Review
- Served as General Counsel and Secretary for Aimmune Therapeutics, Inc., where he managed the legal aspects of the development and commercialization of PALFORZIA, a treatment for peanut allergy
- Worked as Executive Vice President, Chief Administrative Officer, General Counsel, and Secretary of Codexis, Inc., focusing on novel treatments for rare diseases and industrial enzymes
- Previously served as Executive Director, Legal at CV Therapeutics, Inc., focusing on cardiovascular disease treatments
- Started his career as a corporate and securities lawyer in Silicon Valley, representing emerging growth companies and venture funds at Gunderson Dettmer
About Sonoma BioTherapeutics
Sonoma BioTherapeutics is a clinical-stage biotechnology company focused on developing engineered regulatory T cell therapies for autoimmune and inflammatory diseases, with proprietary technologies and a new manufacturing facility in Seattle.
Report inaccurate information
